Hubei Honch Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is MITOMYCIN, with a corresponding US DMF Number 37462.
Remarkably, this DMF maintains an Active status since its submission on October 10, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 27, 2025, and payment made on January 14, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II